| RefID | Source | Author(s) | Title | Year |
|---|---|---|---|---|
| 24 | Literature | Bozoğlan BK, Tunç S and Duman O | Investigation of neohesperidin dihydrochalcone binding to human serum albumin by spectroscopic methods | 2014 |
| 25 | Literature | Braune A, Engst W and Blaut M | Degradation of Neohesperidin Dihydrochalcone by Human Intestinal Bacteria | 2005 |
| 57 | Literature | Fang Y, Cao W, Xia M, Pan S and Xu X | Study of structure and permeability relationship of flavonoids in Caco‐2 cells | 2017 |
| 58 | Literature | Fang Y, Liang F, Liu K, Qaiser S, Pan S and Xu X | Structure characteristics for intestinal uptake of flavonoids in Caco‐2 cells | 2018 |
| 75 | Literature | Han GE, Kang H‐T, Chung S, Lim C, Linton JA, Lee J‐H, Kim W, Kim S‐H and Lee JH | Novel neohesperidin dihydrochalcone analogue inhibits adipogenic differentiation of human adipose‐derived stem cells through the Nrf2 pathway | 2018 |
| 95 | Literature | Johnston K, Sharp P, Clifford M and Morgan L | Dietary polyphenols decrease glucose uptake by human intestinal Caco‐2 cells | 2005 |
| 209 | Literature | Sjöstedt N, Deng F, Rauvala O, Tepponen T and Kidron H | Interaction of Food Additives with Intestinal Efflux Transporters | 2017 |
| 230 | Literature | Waalkens‐Berendsen DH, Kuilman‐Wahls MEM and Bär A | Embryotoxicity and teratogenicity study with neohesperidin dihydrochalcone in rats | 2004 |
| 231 | Literature | Wang X, Pan Y, Ma J, Shi S, Zheng X and Xiang Z | Application of a liquid chromatography‐tandem mass spectrometry method to the pharmacokinetics, bioavailability and tissue distribution of neohesperidin dihydrochalcone in rats | 2014 |
| 286 | Call for data | Gumbmann MR, Gould DH, Robbins DJ and Booth AN (Documentation provided to EFSA nr: 9) | Toxicity studies of neohesperidin dihydrochalcone | 1978 |
| 306 | Call for data | Sequani Limited (Documentation provided to EFSA nr: 9) | Neohesperidin dihydrochalcone: In Vitro mammalian cell micronucleus test | 2018 |
| 307 | Call for data (a) | T.N.O. – Division for Nutrition and Food Research (Documentation provided to EFSA nr: 9) | Sub‐chronic (90‐day) oral toxicity study with neohesperidine dihydrochalcone (NHDC) in rats | 1986 |
| 339 | Call for data/Reply to EFSA clarifications request | Western Regional Research Laboratory (Documentation provided to EFSA nr: 10) | Toxicity study of two flavanone dihydrochalcones (potential artificial sweetening agents) | 1965 |
| 345 | Literature | Zhang FX, Yuan YL, Cui SS, Li M, Tan X, Qiu ZC and Li RM | Dissection of the potential pharmacological function of neohesperidin dihydrochalcone – a food additive – by in vivo substances profiling and network pharmacology | 2021 |
| 354 | Literature | Choi S, Yu S, Lee J and Kim W | Effects of Neohesperidin Dihydrochalcone (NHDC) on Oxidative Phosphorylation, Cytokine Production, and Lipid Deposition | 2021 |
| 360 | Literature | Shi ZJ, Lei HH, Chen G, Yuan PH, Cao Z, Ser HL, Zhu XH, Wu F, Liu CX, Dong MY, Song YC, Guo YY, Chen C, Hu KX, Zhu YF, Zeng XA, Zhou JL, Lu YJ, Patterson AD and Zhang LM | Impaired Intestinal Akkermansia muciniphila and Aryl Hydrocarbon Receptor Ligands Contribute to Nonalcoholic Fatty Liver Disease in Mice | 2021 |
| 789 | Call for data | Bioneeds India Private Limited (Documentation provided to EFSA nr: 11) | In vitro mammalian cell micronucleus test of neohesperidin DC in human lymphocytes | 2022 |
(a)
This unpublished study report was subsequently published as Lina BAR, Dreef‐van der Meulen HC, Leegwater DC, 1990. Subchronic (13‐week) oral toxicity of neohesperidin dihydrochalcone in rats. Food Chemistry and Toxicology, 26(7), 507–513. https://doi.org/10.1016/0278-6915(90)90121-3.